Abiopharma

Gulfport Energy Appoints Domenic J. Dell’Osso, Jr. Chief Executive Officer

Ultragenyx Reports First Quarter 2026 Financial Results and Corporate Update

Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Lumen to Acquire Alkira, Establishing the Control Plane for Cloud Connectivity

Carlsmed® Reports First Quarter 2026 Financial Results

Tempus Reports First Quarter 2026 Results

Avalo Therapeutics Achieves Positive Topline Results in Phase 2 LOTUS Trial of Abdakibart (AVTX-009) in Moderate to Severe Hidradenitis Suppurativa

The Manitowoc Company Reports First-Quarter 2026 Financial Results; Maintains Full Year 2026 Guidance

United Fire Group, Inc. reports first quarter 2026 results

Hyperion DeFi Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants